Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT01632423
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 10,337
Testing effectiveness (Phase 2)Study completedNCT04405245
What this trial is testing

Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
EyePoint Pharmaceuticals, Inc. 194
Testing effectiveness (Phase 2)Study completedNCT01654484
What this trial is testing

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

Who this might be right for
Glaucoma and Ocular Hypertension
Santen Inc. 60
Not applicableUnknownNCT05075226
What this trial is testing

Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma

Who this might be right for
Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Maisonneuve-Rosemont Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01896180
What this trial is testing

Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

Who this might be right for
Primary Open Angle GlaucomaOcular HypertensionElevated Intraocular Pressure
Alleanza Pharmaceuticals, Inc. 63
Early research (Phase 1)Ended earlyNCT01180062
What this trial is testing

Safety Study of Latanoprost Slow Release Insert

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Daniel Moore 12
Not applicableStudy completedNCT03931317
What this trial is testing

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego 70
Not applicableWithdrawnNCT04064918
What this trial is testing

Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego
Early research (Phase 1)Study completedNCT02622334
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).

Who this might be right for
Glaucoma
Hoffmann-La Roche 45
Not applicableStudy completedNCT01999348
What this trial is testing

GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Allergan 1,553
Not applicableStudy completedNCT01628614
What this trial is testing

Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,812
Not applicableStudy completedNCT01737853
What this trial is testing

Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma Primary Open Angle
Allergan S.A. DE C.V.. 90
Not applicableStudy completedNCT01735214
What this trial is testing

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 358
Not applicableStudy completedNCT01628588
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 854
Not applicableStudy completedNCT01589510
What this trial is testing

Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 419